US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class III · Low risk Terminated

Make Up Transparent sand

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1102-2017
Class III · Low risk Terminated

Make Up Transparent pastel

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1101-2017
Class III · Low risk Terminated

Make Up Transparent ivory

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1100-2017
Class III · Low risk Terminated

Beautipharm Eye Care Balm SPF 10

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1099-2017
Class III · Low risk Terminated

Beautipharm Body Moisturizing Balm SPF 10

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1098-2017
Class III · Low risk Terminated

Beautipharm All Day Moisturizing Balm SPF 10

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1097-2017
Class II · Moderate risk Terminated

Magnesium Citrate Oral Solution

Reason Microbial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis.

Vi-Jon, Inc. NDC 50804-686-38 D-1054-2017
Class II · Moderate risk Terminated

Glycopyrrolate Injection Solution

Reason Lack of Sterility Assurance.

Cantrell Drug Company NDC 52533-028-45 D-1067-2017
Class II · Moderate risk Terminated

Glycopyrrolate Injection Solution

Reason Lack of Sterility Assurance.

Cantrell Drug Company NDC 52533-028-16 D-1066-2017
Class II · Moderate risk Terminated

Glycopyrrolate Injection Solution

Reason Lack of Sterility Assurance.

Cantrell Drug Company NDC 52533-028-15 D-1065-2017